Dr. Arjomand is founder of Accium BioSciences and is responsible for Accium’s commercial AMS services and operations. He serves as Scientific Director for Accium’s AMS-based studies and is responsible for each sponsor’s bioanalytical project. Dr. Arjomand obtained his Doctorate in 1998 from the University of California in Davis under the guidance of Dr. Andrew Clifford. He designed and conducted the first human microdosing study using AMS in a joint research effort with Lawrence Livermore National Laboratory (see publications). Prior to co-founding Accium, Dr. Arjomand was Director of Technical Business Development at CombiMatrix Corporation, a publicly traded genomics biotechnology company. As the sixteenth employee hired, Dr. Arjomand co-led the development of commercialization strategies and oversaw the expansion of the company’s DNA chip products into the U.S. and Asian markets. Prior to joining CombiMatrix, Dr. Arjomand was lead technical consultant for chromatography at Bio-Rad Laboratories, a $1B supplier of life science and diagnostics products.
LC School Reviews
“I now have a better understanding of how HPLC works and why column choice is so important.”
“It is a fantastic course for learning the theory of LC and method development”
“The instructor, Merlin Bicking, is very helpful. It was great to see how wiling he is to answer questions and all the variety of methods he worked on.”
“I am just beginning my position from out of school. I found the course very insightful in terms of preparation for my future career”
“It is very useful for me because having hands on experience, which helped me to understand more of HPLC.”
“Great class. Would easily take again and recommend Dr. Merlin anytime. Would love to take his other courses. If he had a book would quickly buy for reference.”
Ali Arjomand, Ph.D.
Dr. Arjomand is founder of Accium BioSciences and is responsible for Accium’s commercial AMS services and operations. He serves as Scientific Director for Accium’s AMS-based studies and is responsible for each sponsor’s bioanalytical project. Dr. Arjomand obtained his Doctorate in 1998 from the University of California in Davis under the guidance of Dr. Andrew Clifford. He designed and conducted the first human microdosing study using AMS in a joint research effort with Lawrence Livermore National Laboratory (see publications). Prior to co-founding Accium, Dr. Arjomand was Director of Technical Business Development at CombiMatrix Corporation, a publicly traded genomics biotechnology company. As the sixteenth employee hired, Dr. Arjomand co-led the development of commercialization strategies and oversaw the expansion of the company’s DNA chip products into the U.S. and Asian markets. Prior to joining CombiMatrix, Dr. Arjomand was lead technical consultant for chromatography at Bio-Rad Laboratories, a $1B supplier of life science and diagnostics products.
LC School Reviews
“I now have a better understanding of how HPLC works and why column choice is so important.”
“It is a fantastic course for learning the theory of LC and method development”
“The instructor, Merlin Bicking, is very helpful. It was great to see how wiling he is to answer questions and all the variety of methods he worked on.”
“I am just beginning my position from out of school. I found the course very insightful in terms of preparation for my future career”
“It is very useful for me because having hands on experience, which helped me to understand more of HPLC.”
“Great class. Would easily take again and recommend Dr. Merlin anytime. Would love to take his other courses. If he had a book would quickly buy for reference.”